LGD-2941

LGD-2941
Identifiers
  • 6-[(2R,5R)-2-methyl-5-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-4-(trifluoromethyl)-1H-quinolin-2-one
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC17H16F6N2O2
Molar mass394.317 g·mol−1
3D model (JSmol)
  • C[C@@H]1CC[C@@H](N1C2=CC3=C(C=C2)NC(=O)C=C3C(F)(F)F)[C@H](C(F)(F)F)O
  • InChI=InChI=1S/C17H16F6N2O2/c1-8-2-5-13(15(27)17(21,22)23)25(8)9-3-4-12-10(6-9)11(16(18,19)20)7-14(26)24-12/h3-4,6-8,13,15,27H,2,5H2,1H3,(H,24,26)/t8-,13-,15-/m1/s1
  • Key:HWLLYFXDDGGHOE-BCSUUIJWSA-N

LGD-2941 is a drug which acts as a selective androgen receptor modulator (SARM).[1] It is no longer being developed.[2]

References

  1. ^ Long YO, Higuchi RI, Caferro TR, Lau TL, Wu M, Cummings ML, Martinborough EA, Marschke KB, Chang WY, López FJ, Karanewsky DS, Zhi L (May 2008). "Selective androgen receptor modulators based on a series of 7H-[1,4]oxazino[3,2-g]quinolin-7-ones with improved in vivo activity". Bioorganic & Medicinal Chemistry Letters. 18 (9): 2967–71. doi:10.1016/j.bmcl.2008.03.062. PMID 18400499.
  2. ^ "LGD 2941". AdisInsight. Springer Nature Switzerland AG.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.